Efficacy Of Pregabalin In The Treatment Of Pancreatic Cancer Pain. A Randomized Controlled Double-Blind, Parallel Group Study.

Trial Profile

Efficacy Of Pregabalin In The Treatment Of Pancreatic Cancer Pain. A Randomized Controlled Double-Blind, Parallel Group Study.

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 10 Oct 2017

At a glance

  • Drugs Pregabalin (Primary)
  • Indications Abdominal pain; Cancer pain
  • Focus Therapeutic Use
  • Acronyms PANPAIN1
  • Most Recent Events

    • 04 Oct 2017 Planned primary completion date changed from 1 Jun 2017 to 1 Dec 2017.
    • 04 Oct 2017 Status changed from recruiting to discontinued.
    • 30 Sep 2016 Results of preliminary analysis assessing efficacy, presented at the 16th World Congress on Pain
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top